Our primary focus is on the biopharmaceuticals derived from the
botulinum neurotoxin as therapeutics. As the first project, we
developed a botulinum toxin type A product as injectables. We are
also working on the development B & E products.
The specification of our product is equivalent and/or superior to
those of other competitors. Especially, our extreme focus is on the
highest quality control/assurance and the minimal variation of the
toxin quantity in a vial.
Dosage Form: Inject able
Appearance: A White Lyophilized Cake
Composition in 1 Vial
Active Pharmaceutical Ingredient: 100 units*
Human Serum Albumin: 0.5 mg
Sodium Chloride: 0.9 mg
* ICR Mouse LD50